T. Mayo, “Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials”, J of Skin, vol. 6, no. 6, p. s76, Nov. 2022.